-+ 0.00%
-+ 0.00%
-+ 0.00%

Dentsply Sirona Stock Faces A Digital Dentistry And Restructuring Test

Simply Wall St·09/18/2026 12:26:17
Listen to the news
  • DENTSPLY SIRONA has outlined plans to pursue growth through heavier investment in digital dentistry, continued R&D, and a restructuring program aimed at meaningful cost savings and tighter expense control.
  • The same plan highlights real operating pressure, with softness in CAD/CAM, implants, SureSmile, tariffs, and freight costs testing whether the restructuring can genuinely free up resources for higher priority growth projects.
  • We will now see how DENTSPLY SIRONA's investment narrative could be reshaped by its push into digital dentistry, supported by restructuring.

Scan how DENTSPLY SIRONA’s digital push compares with peers by checking a curated 16 high quality undiscovered gems built around companies leaning into technology and operational resets.

DENTSPLY SIRONA Investment Narrative Recap

For DENTSPLY SIRONA, the investment case still leans on a simple idea. The business needs its digital dentistry bet and restructuring to offset pressure in higher margin categories like CAD/CAM, implants, and SureSmile. The recent update reinforces that this is a real execution challenge, not a clean growth story, with tariffs and freight costs still biting.

In the near term, the key swing factor is whether cost savings actually show up in reported margins while core product demand remains soft. The biggest risk is that volume in elective and premium segments stays weak, which would leave restructuring benefits absorbed by tariffs, freight, and ongoing competitive pressure rather than visible in earnings.

One of the most relevant developments around DENTSPLY SIRONA is its sharper focus on digital platforms such as DS Core and tightly integrated hardware and software. That push aligns with the goal of more recurring, workflow-based revenue rather than one-off equipment sales. This shift could help reduce earnings volatility over time if adoption holds up.

This same move is tied directly to the current catalysts and risks. Success would mean clinicians lean into full digital workflows, supporting better utilization of scanners, mills, and aligner systems. Shortfalls would expose the firm to the existing pain points in CAD/CAM and implants without the offset of higher margin software and services, leaving restructuring to carry almost all the weight.

DENTSPLY SIRONA's current loss of $628.0 million is set against analyst expectations for earnings of $189.7 million by 2029, which implies an earnings improvement of about $817.7 million and forecast revenues of $3.8b in the same year, even as consensus assumes revenue remains fairly flat over the next few years.

Uncover why DENTSPLY SIRONA's fair value indicates a 43% potential upside to its current price, a gap that could narrow quickly.

NasdaqGS:XRAY 1-Year Stock Price Chart
NasdaqGS:XRAY 1-Year Stock Price Chart

Exploring Other Perspectives

Some of the most optimistic analysts focus on one thing. They see DENTSPLY SIRONA’s DS Core and AI features as the real swing factor. Before this news, the bullish camp projected revenue of about US$3.9b and earnings of roughly US$373.4 million by 2029. That is far above the most cautious US$93.8 million view. These forecasts were set before the latest update, so you may want to compare them with your own read of how digital adoption and restructuring could change from here.

Explore 2 other DENTSPLY SIRONA fair value estimates, including one that suggests as much as 385% upside from the current price.

Form Your Own Verdict

Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

  • A great starting point for your DENTSPLY SIRONA research is our analysis highlighting 4 key rewards that could impact your investment decision.
  • See our latest analysis for DENTSPLY SIRONA. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate DENTSPLY SIRONA's overall financial health at a glance.

Looking For More Investment Ideas Beyond DENTSPLY SIRONA?

If the DENTSPLY SIRONA story has sharpened your thinking, use that momentum to widen your watchlist. Different business models and balance sheet profiles can stress test your thesis and help you see where the real trade offs sit.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.